Virtus Biotech Clinical Trials ETF share price logo

Virtus Biotech Clinical Trials ETF

$52.91

-0.14

(-0.26%)

as on

Virtus Biotech Clinical Trials ETF Stock Performance

as on September 2, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $52.22
    $52.94
    downward going graph

    1.30%

    Downside

    0.06%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $22.43
    $56.18
    downward going graph

    57.61%

    Downside

    6.18%

    Upside

    downward going graph

Virtus Biotech Clinical Trials ETF share price movements today

AUM
$52.6M
Expense Ratio
0.65%
NAV
$55.38
Market Cap
$52.6M
Dividend Yield
118.44%
Volume
133.1K
Day's Low - High
$52.22 - $52.94
52 Week Low - High
$22.43 - $56.18

Virtus Biotech Clinical Trials ETF Fundamentals

Expense Ratio0.65%
Avg. PE ratioNA
Avg. PB ratioNA
AUM₹52615817

Companies in Virtus Biotech Clinical Trials ETF

Portfolio Breakup

Sector

Healthcare
100.00%

Market Cap

Small Cap
21.88%
Micro Cap
73.05%
Mid Cap
2.01%

Insights on Virtus Biotech Clinical Trials ETF

Insights help you understand the recent movement of the ETF's critical parameters, giving you an overall view of the ETF.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 5 years, Virtus Biotech Clinical Trials ETF has moved up by 11.63%

  • imgNO EFFECT

    Market Cap Breakup

    img

    Market Cap breakup for Virtus Biotech Clinical Trials ETF is 73.05% in Micro Cap, 21.88% in Small Cap, 2.01% in Mid Cap, 0.00% in Large Cap and 0.00% in Mega Cap with top sector being Healthcare with 100.00%

About Virtus Biotech Clinical Trials ETF

This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
ExchangeARCA

Frequently Asked Questions

What is Virtus Biotech Clinical Trials ETF (BBC) share price today?

Virtus Biotech Clinical Trials ETF (BBC) share price today is $52.91.

Can Indians buy Virtus Biotech Clinical Trials ETF shares?

Yes, Indians can invest in the Virtus Biotech Clinical Trials ETF (BBC) from India.

With INDmoney, you can buy Virtus Biotech Clinical Trials ETF at 0 brokerage. The step-by-step process is as follows:

• Open your zero cost US Stocks account and zero balance IND Super Saver Account Powered by SBM India Bank (this can be done in less than 3 minutes)

• Transfer funds to your US Stocks account using your IND Super Saver Account (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.

• Once funds are transferred successfully, you can buy Virtus Biotech Clinical Trials ETF at zero transaction cost.

How can I buy Virtus Biotech Clinical Trials ETF shares from India?

It is very easy to buy Virtus Biotech Clinical Trials ETF from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Virtus Biotech Clinical Trials ETF be purchased?

Yes, you can buy fractional shares of Virtus Biotech Clinical Trials ETF with INDmoney app.

What are the documents required to start investing in Virtus Biotech Clinical Trials ETF stocks?

To start investing in Virtus Biotech Clinical Trials ETF, You will need the following documents:

• Proof of Identification (PAN, Aadhaar etc)

• Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND Super Saver Account powered by SBM Bank so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.